From a young age, Allie Greenstone had known that she wanted to work with cannabis. When, during her college years in Michigan, medical marijuana ended up on the ballot, she printed over a hundred T-shirts that read “Yes to Prop 1” in a kitschy, leafy font. Fittingly, she started her career as a budtender in Denver, while also keeping up with the latest in cultivar and cannabinoid research.
Greenstone’s well-rounded knowledge of and appreciation for cannabis would eventually land her a place at Mary’s Medicinals, where she now works as a brand representative and national educator. The first job speaks for itself, but the second might require a bit of an explanation. In short, Greenstone is responsible for educating the brand’s budtenders and informing its consumers.
The role of educator isn’t exactly common among cannabis companies, many of which prioritize marketing over R&D. But for Mary’s—a Denver-based, female-led business founded in 2013—learning and growing have always been part of the curriculum. Even as the brand expands into uncharted territory, its mission to “distill the wisdom of plants” continues to govern day-to-day operations.
Courtesy of Mary’s Medicinals Mary’s Medicinals Presents: Pens and Patches
Bridging the gap between technology and horticulture, Mary’s Medicinals delivered one of the first patented cannabis products in the United States: the transdermal gel pen. The pen, which has been released in CBD, CBN, Indica and Sativa varieties, provides consistent and reliable effects the likes of which—according to consumers, at least—purely recreational cannabis simply cannot offer.
Greenstone and her colleagues would concur, as Mary’s was the first and—to this day—one of regrettably few cannabis brands that tests products at its own locations in addition to third-party research facilities. Armed with its own team …
Author: Tim Brinkhof / High Times